“Trastuzumab-Conjugated Nanoparticles: Design And Synthesis Of Trastuzumab-Conjugated Nanoparticles For Targeted Delivery Of Chemotherapeutic Agents To Her2-Positive Breast Cancer Cells”. 2025. Vascular and Endovascular Review 8 (12s): 310-15. https://verjournal.com/index.php/ver/article/view/957.